Publishing research using ab6507? Please let us know so that we can cite the reference in this datasheet.

ab6507 has been referenced in 7 publications.

  • Çuburu N  et al. Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge. J Virol 89:83-96 (2015). WB . PubMed: 25320297
  • Abe T & Barber GN Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-?B activation through TBK1. J Virol 88:5328-41 (2014). PubMed: 24600004
  • MacLeod DT  et al. HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection. Nat Commun 4:1963 (2013). WB . PubMed: 23739639
  • Del Campo J  et al. Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice. Vaccine 28:1193-200 (2010). WB . PubMed: 19945418
  • Reszka NJ  et al. Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein. Vaccine 28:2754-62 (2010). WB . PubMed: 20117270
  • O'Donnell CD & Shukla D A novel function of heparan sulfate in the regulation of cell-cell fusion. J Biol Chem 284:29654-65 (2009). PubMed: 19726670
  • Tengvall S  et al. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice. J Reprod Immunol 68:53-69 (2005). PubMed: 16229896

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"